hexamethylene bisacetamide has been researched along with deferoxamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gambari, R | 1 |
Battistini, A; Coccia, EM; Orsatti, R; Stellacci, E; Testa, U | 1 |
Kiyokawa, H; Marks, PA; Richon, VM; Rifkind, RA; Venta-Perez, G | 1 |
3 other study(ies) available for hexamethylene bisacetamide and deferoxamine
Article | Year |
---|---|
Desferrioxamine-mediated inhibition of heme and hemoglobin synthesis in murine erythroleukemia cells: expression of globin genes and commitment to erythroid differentiation.
Topics: Acetamides; Animals; Cell Differentiation; Cell Division; Cells, Cultured; Deferoxamine; Erythropoiesis; Gene Expression Regulation; Globins; Heme; Hemoglobins; Leukemia, Erythroblastic, Acute; Mice | 1983 |
Regulation of ferritin H-chain expression in differentiating Friend leukemia cells.
Topics: Acetamides; Animals; Cell Differentiation; Deferoxamine; Dimethyl Sulfoxide; Erythroid Precursor Cells; Erythropoiesis; Ferritins; Gene Expression; Hemin; In Vitro Techniques; Leukemia, Erythroblastic, Acute; Mice; Protein Biosynthesis; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.
Topics: Acetamides; Animals; Aphidicolin; Cell Differentiation; Cyclins; Deferoxamine; G1 Phase; Leukemia, Erythroblastic, Acute; Mice; Retinoblastoma Protein; Time Factors; Tumor Cells, Cultured | 1993 |